2004
DOI: 10.7326/0003-4819-141-3-200408030-00005
|View full text |Cite
|
Sign up to set email alerts
|

Sildenafil Increased Exercise Capacity during Hypoxia at Low Altitudes and at Mount Everest Base Camp

Abstract: Sildenafil reduces hypoxic pulmonary hypertension at rest and during exercise while maintaining gas exchange and systemic blood pressure. To the authors' knowledge, sildenafil is the first drug shown to increase exercise capacity during severe hypoxia both at sea level and at high altitude.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

10
183
1
10

Year Published

2004
2004
2019
2019

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 279 publications
(207 citation statements)
references
References 34 publications
10
183
1
10
Order By: Relevance
“…[9][10][11] The phosphodiesterase-5 (PDE5) inhibitor sildenafil has been shown to improve pulmonary hemodynamics and exercise capacity in adults with group 1 pulmonary hypertension (PH) (defined by right heart catheterization [RHC] as a mean pulmonary artery pressure Ն 25 mmHg, a pulmonary artery occlusion pressure or a left ventricular end diastolic pressure Յ 15 mmHg, and an increased pulmonary vascular resistance) 12 : idiopathic or heritable pulmonary arterial hypertension (PAH), or PAH associated with connective tissue diseases or repaired congenital systemic to pulmonary shunts. 13 Further, sildenafil has been shown to improve exercise capacity in patients with left ventricular systolic dysfunction and pulmonary venous hypertension (defined via cardiac catheterization as a mean pulmonary artery pressure Ն 25 mmHg and a pulmonary artery occlusion pressure or a left ventricular end diastolic pressure Ն 15 mmHg) 14,15 and in healthy volunteers exposed to experimental hypoxia or high altitude, 16,17 suggesting a beneficial role of PDE5 inhibition in patients with group 2 PH (PH with left heart disease) and group 3 PH (PH associated with lung diseases and/or hypoxemia). PDE5 inhibition also prevents and reverses cardiac hypertrophy in mice exposed to chronic left ventricular pressure overload induced by transverse aortic constriction.…”
Section: Introductionmentioning
confidence: 99%
“…[9][10][11] The phosphodiesterase-5 (PDE5) inhibitor sildenafil has been shown to improve pulmonary hemodynamics and exercise capacity in adults with group 1 pulmonary hypertension (PH) (defined by right heart catheterization [RHC] as a mean pulmonary artery pressure Ն 25 mmHg, a pulmonary artery occlusion pressure or a left ventricular end diastolic pressure Յ 15 mmHg, and an increased pulmonary vascular resistance) 12 : idiopathic or heritable pulmonary arterial hypertension (PAH), or PAH associated with connective tissue diseases or repaired congenital systemic to pulmonary shunts. 13 Further, sildenafil has been shown to improve exercise capacity in patients with left ventricular systolic dysfunction and pulmonary venous hypertension (defined via cardiac catheterization as a mean pulmonary artery pressure Ն 25 mmHg and a pulmonary artery occlusion pressure or a left ventricular end diastolic pressure Ն 15 mmHg) 14,15 and in healthy volunteers exposed to experimental hypoxia or high altitude, 16,17 suggesting a beneficial role of PDE5 inhibition in patients with group 2 PH (PH with left heart disease) and group 3 PH (PH associated with lung diseases and/or hypoxemia). PDE5 inhibition also prevents and reverses cardiac hypertrophy in mice exposed to chronic left ventricular pressure overload induced by transverse aortic constriction.…”
Section: Introductionmentioning
confidence: 99%
“…Su papel como posible factor para aumentar el rendimiento en el ejercicio en condiciones de hipoxia está por demostrar, pero el uso de sildenafilo ha aumentado entre los montañeros, no como un fármaco preventivo del edema pulmonar de gran altitud, sino en la creencia de que podría ayudar a mejorar el rendimiento físico a gran altura geográfica. Varios estudios han tratado de abordar este tema, con resultados Since the work of Ghofrani et al 1 about the improvement of physical capacity during exercise in hypoxia conditions due to the use of sildenafil, 1 several studies have attempted to reproduce their findings. However, to date, there is still controversy over whether phosphodiesterase type 5 (PDE-5) inhibitor is a substance that can actually improve performance under hypoxic conditions.…”
Section: Palabras Claveunclassified
“…These authors analyzed 5 articles, 3 of which have already been commented above. 1,14,29 It was evident that sildenafil administration is able to blunt the PAP increase induced by hypoxia exposure, but it does not improved SaO 2 and HR. Moreover, acute mountain sickness symptoms were not relieved by sildenafil treatment.…”
Section: Sildenafil Effects During Exercise and Hypoxiamentioning
confidence: 99%
See 2 more Smart Citations